URMC awarded up to $9 million to study infectious diseases
Rochester, N.Y. (WHAM) - Over the next five years, the University of Rochester Medical Center (URMC) is set to receive up to $9 million from the Centers for Disease Control and Prevention (CDC).
The funding is directed at watching for and researching infectious diseases.
URMC is part of the New York State Emerging Infections Program (EIP), which works with the New York State Department of Health to track diseases that have a big impact on the public, and look into new therapies and prevention methods.
Some of those disease include flu, HPV, and C. diff.
“This is the largest national surveillance system for infectious diseases, and most of what we know about the burden of infectious disease in the U.S. comes from the research conducted in this network,” said Nancy M. Bennett, M.D., director of the Center for Community Health and co-principal investigator of the New York State EIP. “This is our 20th year working with the CDC. Rochester is an ideal community for this research due to the incredible collaboration of physicians, health care institutions and laboratories in our region.”
Ghinwa Dumyati, M.D., director of the Communicable Diseases Surveillance and Prevention program at the Center for Community Health, leads the program with Nancy M. Bennett, M.D. They will work with nurses, infection preventionists and health project coordinators to track flu and RSV to assess how effective vaccines are, as well as pneumonia and C. diff in nursing homes, and the emergence of antibiotic-resistant organisms.